greeksoup/ stock research

AmpliTech Group, Inc. SEC filings

AmpliTech Group filed 28 documents with the SEC in the last twelve months, the latest report being the 10-Q of 13 August 2026. The latest filing, on 13 October 2026, was a DEFA14A: defa14a.

Filings in twelve months2818 of them 8-K news
Latest report10-Qfiled 13 Aug 2026
Latest filingDEFA14A13 Oct 2026
Last results, two-day move-37.8%results filed 13 Aug 2026
New to this? How to read this page
  1. Companies file with the SEC when something happens. 10-Q and 10-K are the quarterly and annual reports; 8-K is news that cannot wait for the next report.
  2. An 8-K says which items it covers, such as results, a change at the top or a big contract. A foreign company files a 6-K instead.
  3. The results release is usually an 8-K filed the day results come out, before the 10-Q or 10-K.
  4. Every filing links to the original on EDGAR, the SEC's own site.

Twelve months of filings

by kind

Most of the filings were other company news (15). Results came out 3 times.

Each mark is one filing on the day it was filed, in rows by kind. Hover or tap a mark for the form and what it was about.

The share price around each results release

close before to close after

Over the last 3 releases the share price moved 17.3% on average in the two days around results, the most on 13 Aug 2026 (-37.8%).

5 Jan 2026+7.3%$3.28 to $3.52
13 May 2026+6.7%$2.69 to $2.87
13 Aug 2026-37.8%$6.41 to $3.99
Daily closeResults filed

Each ring marks a results filing. The move runs from the last close before the filing to the first close after it, so it covers results released before the open or after the close. Hover the line for any day's close.

What the company told investors on 8-K

18 filings

AmpliTech Group's 18 news filings (8-K) were mostly about regulation FD disclosure (6) and other events (5).

  • Regulation FD disclosureMaterial shared with investors, often slides or a presentation
    6 · latest 17 Aug 2026
  • Other eventsNews the company chose to file
    5 · latest 22 Jul 2026
  • Officer or director changeSomeone joined, left or changed role at the top
    5 · latest 16 Mar 2026
  • Results of operationsThe quarterly results release
    3 · latest 13 Aug 2026
  • Material agreementA large contract or deal was signed
    3 · latest 12 Aug 2026
  • Termination of a material agreementA large contract ended
    1 · latest 8 Jul 2026
  • Shareholder voteResults of a vote at a shareholder meeting
    1 · latest 15 Dec 2025

Each line is one kind of news, with what it means in plain words. Each square is one filing; a filing can carry more than one kind, so the squares can add up to more than the filings. The date opens the latest one on EDGAR.

How it compares

every company on the site

    The bar ranks every company on the site from the lowest on the left to the highest on the right, in three equal thirds; the small figures under it are the values where each third starts, and the black tick is the middle company. The orange dot is this company; the grey ticks are the other companies in its industry (hover or tap for names). A hatched block is companies tied at none.

    Every filing as a table

    In the last twelve months AmpliTech Group, Inc. filed 28 documents with the SEC of the kinds listed here: 18 current reports (8-K), about 6 regulation FD disclosure; 5 other events; 5 officer or director change; 3 results of operations; 3 material agreement; 3 quarterly reports (10-Q), 2 additional proxy materials (DEFA14A), 2 exchange notice removing a listed security, usually a note or a class of shares (25-NSE), 1 proxy statement (DEF 14A), 1 employee share plan registration (S-8), 1 annual report (10-K). The latest, filed 13 October 2026: DEFA14A, additional proxy material. The 10-K, the 10-Qs and the proxy statement themselves, each with a link to open it, are on the documents page.

    FiledFormWhat it was aboutPeriod or event dateFiling
    13 October 2026DEFA14Aadditional proxy materialEDGAR
    13 October 2026DEF 14Aproxy statement13 October 2026EDGAR
    17 August 20268-KRegulation FD disclosure17 August 2026EDGAR
    13 August 20268-KResults of operations13 August 2026EDGAR
    13 August 202610-Qquarterly report30 June 2026EDGAR
    12 August 20268-KMaterial agreement6 August 2026EDGAR
    22 July 20268-KOther events20 July 2026EDGAR
    20 July 202625-NSEexchange notice removing a listed security, usually a note or a class of sharesEDGAR
    8 July 20268-KTermination of a material agreement, Other events7 July 2026EDGAR
    22 June 20268-KOther events22 June 2026EDGAR
    13 May 20268-KResults of operations13 May 2026EDGAR
    13 May 202610-Qquarterly report31 March 2026EDGAR
    15 April 2026S-8employee share plan registrationEDGAR
    26 March 202610-Kannual report31 December 2025EDGAR
    16 March 20268-KOfficer or director change10 March 2026EDGAR
    18 February 202625-NSEexchange notice removing a listed security, usually a note or a class of sharesEDGAR
    2 February 20268-KMaterial agreement, Officer or director change, Regulation FD disclosure27 January 2026EDGAR
    26 January 20268-KMaterial agreement, Officer or director change20 January 2026EDGAR
    26 January 20268-KRegulation FD disclosure26 January 2026EDGAR
    12 January 20268-KOther events12 January 2026EDGAR
    5 January 20268-KResults of operations5 January 2026EDGAR
    15 December 20258-KOfficer or director change, Shareholder vote10 December 2025EDGAR
    11 December 20258-KOther events11 December 2025EDGAR
    14 November 20258-KRegulation FD disclosure14 November 2025EDGAR
    14 November 202510-Qquarterly report30 September 2025EDGAR
    12 November 20258-KOfficer or director change, Regulation FD disclosure6 November 2025EDGAR
    3 November 20258-KRegulation FD disclosure3 November 2025EDGAR
    3 November 2025DEFA14Aadditional proxy materialEDGAR
    An 8-K is what a company files within four business days of a material event; the SEC numbers the events, and the words here are the SEC's own headings, shortened.
    Read moreForm 4, Form 144, 13F and Schedule 13D and 13G have their own pages. Prospectus supplements and correspondence are not listed.